Drug Enforcement Administration
Skip Navigation

Press Room
News Releases
E-mail updates red envelope
Speeches & Testimony
Multi-Media Library

About Us
Mission
Leadership
History
Organizational Chart
Programs & Operations
Wall of Honor
DEA Museum
Office Locations

Careers at DEA

DEA Drug Information
Drug Information Resources

Law Enforcement
Most Wanted
Major Operations
Threat Assessment
Training Programs
Stats & Facts
Additional Resources

Drug Prevention
For Young Adults
For Parents
Additional Drug Resources

Diversion Control & Prescription Drugs
Registration
Cases Against Doctors

Drug Policy
Controlled Substances Act
Federal Trafficking Penalties
Drug Scheduling

Legislative Resources

Publications

Acquisitions & Contracts

Need to know more about drugs?  www.justthinktwice.com

GetSmart About Drugs - A DEA Resource for Parents

News Release
FOR IMMEDIATE RELEASE
October 4, 2006

Doctor Sentenced to 15 Years in Federal Prison
Health Care Provider Found Guilty of Dispensing Oxycontin without a Legitimate Medical Purpose

DEA Chicago Special Agent in Charge Gary Olenkiewicz announced that Dr. David Demaret Chube II was sentenced in the Northern District of Indiana to fifteen years and 8 months in a federal prison for violating the Controlled Substances Act. The sentence is the result of his conviction May 1, 2006, on a six count indictment charging Chube with four counts of dispensing controlled substances (oxycotin) without a legitimate medical purpose in violation of Title 21 USC Section 841 (A)(1); and two counts for health care fraud in violation of Title 18, USC Sections 1347 and 2. Chube is also facing a $60,000 fine to be paid directly to the District Court. His brother and business partner, Dr. Charles Randall Chube, was also sentenced for dispensing controlled substances without a legitimate medical purpose.

“This sentencing sends a message to the medical community that they are not untouchable when they prescribe narcotics for no legitimate reason,” Olenkiewicz said. This investigation was successful due to the combined efforts between the DEA, FBI, FDA, and the Indiana Attorney General’s Medical Fraud Control Unit. We will continue to work with our partners in the law enforcement community to keep rogue doctors from harming our citizens.”

The investigation involved the doctors selling oxycotin to patients from southwest Michigan and Indiana who then distributed it in the Gary, Indiana area. The case was prosecuted by the United States Attorney’s office in Hammond, Indiana.

 

Home USDOJ.GOV Privacy Policy Contact Us Site Map